On June 13, 2026 Principal, Ms. Pauli Wong spoke at the “Entrepreneurial Workshop,” an elective course under the Master of Technology Entrepreneurship program at the Hong Kong Polytechnic University (PolyU).

Invited as the course's external expert, Pauli shared her extensive expertise with an audience of approximately 35 aspiring tech entrepreneurs, primarily from mainland China.

The interactive session focused on the highly relevant topic “如何运用专利构建科技企业的护城河” (How to Use Patents to Build a Moat for Tech Enterprises).” Drawing from her deep background in patent drafting and global prosecution, Pauli provided real-world case studies, strategic advice, and practical insights on how startups can effectively leverage intellectual property as a defensive moat to protect their tech innovations and scale their businesses safely.

我们的过去活动

Recommended Insights

CHINA: New Patent Examination Guidelines Now Available for Public Comment

2021年8月4日
Two months after the new Chinese Patent law came into effect, the CNIPA has released a new set of Patent Examination Guidelines (proposed version) for public comments on Aug 3, 2021. Here are the explanation of the amendments (Chinese only). Here is the full set of proposed amendments (Chinese only). Briefly, the new amendment focuses […]

Beijing IP Court Reverses CNIPA Decision and Upholds Ozempic® semaglutide patent in China as VALID based on Novo Nordisk’s Post Filing Data

2024年6月27日
Recently, all eyes have been on China as the fundamental patent covering semaglutide, the active ingredient in Ozempic® and Wegovy®, will expire on March 20, 2026. It goes without saying that generics are ramping up bigtime in China (and also around the world), preparing to manufacture and sell this blockbuster drug to one of the […]

China Releases Details on Patent Term Extension, Deferred Examination and More in the Latest Draft Implementation Rules of the New Chinese Patent Law

2020年12月11日
The China National Intellectual Property Administration (CNIPA) is moving forward at breakneck speeds aiming to get all the necessary pieces in place for the June 1, 2021 date when the new 4th Amendment of the Patent Law will come into effect. Most recently, this means a flurry of drafts coming out from CNIPA, including, but […]

Do Promotional Marketing Materials Constitute an “Offer for Sale” under Chinese Patent Law? Bayer IP GmbH v. Nanjing Hang Seng Pharmaceutical

2023年12月12日
Bayer's blockbuster drug Rivaroxaban has seen its share of patent litigations in China, several of which are big enough to be listed as Top 10 IP cases or 50 Representative IP cases. We summarized an invalidation case back in 2020 where all of Bayer’s claims directed towards the compound were upheld. Recently, another Rivaroxaban case […]
Top crossarrow-right